- Abemaciclib, Its Intermediates(2)
- Regorafenib, Its Intermediates(5)
- ABT-199, Its Intermediates(8)
- Nintedanib, Intermediates(2)
- Cobimetinib, Its Intermediates(1)
- OTHERS(7)
- Cinacalcet, Its Intermediates(8)
- lenvatinib, Its Intermediates(2)
- Ibrutinib, Its Intermediates(1)
- Nilotinib, Its Intermediates(12)
- Pazopanib, Its Intermediates(12)
- Dovitinib, Its Intermediates(1)
- Dasatinib, Its Intermediates(4)
- Vandetanib, Intermediates(9)
- Sorafenib, Its Intermediates(5)
- Gefitinib, Its Intermediates(2)
Country: | China |
---|---|
Tel: | |
Mobile: | +86-18752526868 |
E-mail: | jennysun@yzqyyykj.com |
QQ: | 1035253726 |
Skype: | Chat Now! |
Address: | No.168 Zhicheng Road Industrial District Maji Town Yizheng City Jiangsu Province China |
-
(R)-(+)-1-(1-Naphthyl)ethylamine hydrochloride
CAS:82572-04-1 -
CinacalcetHydrochloride
CAS:364782-34-3 -
N-((R)-1-(naphthalen-1-yl)ethyl)-3-(3-(trifluoroMethyl)phenyl)propanaMide
CAS:1005450-55-4 -
3-[3-(Trifluoromethyl)phenyl]prop-2-enoic acid
CAS:779-89-5 -
Cinacalcet
CAS:226256-56-0 -
3-(3-Trifluoromethylphenyl)propionicacid
CAS:585-50-2 -
(S)-(-)-1-(1-Naphthyl)ethylamine
CAS:10420-89-0 -
(R)-(+)-1-(1-Naphthyl)ethylamine
CAS:3886-70-2